BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Business

  Azenta Reports Results of Third Quarter of Fiscal 2023, Ended June 30, 2023

  Azenta, Inc. reported financial results for the third quarter ended June 30, 2023.

  August 8, 2023

   · 

  24 min read
• Business

  Personalis Reports Second Quarter 2023 Financial Results

  Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, today reported financial results for the second quarter ended June 30, 2023 and provided recent business highlights.

  August 8, 2023

   · 

  9 min read
• Business

  Ligand Reports Second Quarter 2023 Financial Results

  Ligand Pharmaceuticals Incorporated reported financial results for the three and six months ended June 30, 2023, and provided an operating forecast and business updates.

  August 8, 2023

   · 

  28 min read
• Business

  Viridian Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update

  Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biotechnology company focused on discovering and developing potential best-in-class medicines for serious and rare diseases, today announced financial results and provided a corporate update for the second quarter ended June 30, 2023.

  August 8, 2023

   · 

  10 min read
• Business

  Acorda Therapeutics Reports Second Quarter 2023 Financial Results

  Acorda Therapeutics, Inc. (Nasdaq: ACOR) today provided a business update and reported its financial results for the second quarter ended June 30, 2023.

  August 8, 2023

   · 

  14 min read
• Biotech Beach

  Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2023

  Amphastar Pharmaceuticals, Inc. reported results for the three months ended June 30, 2023.

  August 8, 2023

   · 

  16 min read
• Business

  Emergent BioSolutions Reports Financial Results for Second Quarter 2023

  Emergent BioSolutions Inc. (NYSE: EBS) today reported financial results for the second quarter ended June 30, 2023. It also announced strategic steps to reduce investment in and de-emphasize focus on growth in its CDMO business.

  August 8, 2023

   · 

  35 min read
• BioMidwest

  Assertio Holdings, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - August 08, 2023

  Assertio Holdings, Inc. announced that effective July 31, 2023, the Compensation Committee of the Company’s Board of Directors granted eight newly-hired employees a total of 82,341 restricted stock units and 92,591 stock options.

  August 8, 2023

   · 

  3 min read
• Business

  QuidelOrtho Reports Second Quarter 2023 Financial Results

  QuidelOrtho Corporation, a global provider of innovative in vitro diagnostic technologies designed for point-of-care settings, clinical labs and transfusion medicine, announced financial results for the second quarter ended July 2, 2023.

  August 8, 2023

   · 

  19 min read
• Business

  Vistagen To Report First Quarter Financial Results and Host Corporate Update Conference Call on August 10, 2023

  Vistagen (NASDAQ: VTGN) today announced it will host a conference call and webcast on Thursday, August 10, 2023, at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time) to provide a corporate update and report results for its fiscal year 2024 first quarter ended June 30, 2023.

  August 8, 2023

   · 

  2 min read